In silico Platform for designing genome-based
Personalized immunotherapy or Vaccine against Cancer

Predicted Immune Epitope Results

The result page of search shows exclusive peptide/epitopes generated due to mutation [Neoepitope], the tissue of origin [Tissue], position of peptide in protein [Position], number of mismatches counted by aligning mutated and normal protein sequence [Num Mismatch, percentage of cell lines with this peptide over total number of cell lines [Promiscuity %]. The immune information include CTL epitopes (Yes/No), MHC I binders, MHC II binders (both given as number of alleles) and B cell epitopes (Yes/No). For more information, please click HERE

NeoepitopesWSIWMTETL        Click here to BLAST against human proteome
CTL Epitope
HLA I Alleles
(ProPred I)
HLA-B*3501, HLA-B*3902, HLA-B40, HLA-B*51, HLA-B*5301, HLA-B*5401, HLA-B*5801, HLA-B60, HLA-B7, HLA-Cw*0301, HLA-Cw*0602, MHC-Db, MHC-Db revised, MHC-Kb, MHC-Kd, MHC-Ld16
HLA I Alleles
HLA-A2, HLA-Cw*0401, H2-Db, H2-Dd, H2-Kb, H2-Kd, H2-Ld, HLA-G, H-2Qa, Mamu-A*01, HLA-A*680211
HLA II Alleles
DRB1_0405, DRB1_0408, DRB1_0701, DRB1_07034

CANCERTOPE    |     Raghava's Group    |     IMTECH    |     CSIR    |     CRDD    |     GPSR Package